-The Indina Express The proposal holds significance given that the EC Act arms the government with powers to impose stock limits and movement restrictions on agricultural commodities. New Delhi: Arguing that the Essential Commodities Act, 1955, was framed during the era of food scarcity, the NITI Aayog has proposed that the Act be scrapped because it is an “impediment in the free movement of commodities” given that the country is now...

-The Times of India NEW DELHI: Around 40% of the essential medicines in India with lowest MRP are priced significantly higher than estimated production costs, an assessment by the World Health Organisation (WHO) shows highlighting the “exorbitant” profiteering by pharmaceutical companies and the scope for lowering prices of drugs. While innovative and newer drugs for cancer, hepatitis C and rare diseases are out of reach of many due to their unaffordable prices,...

-The Telegraph Call to govt to adopt 'cost-based' control The 30 per cent cap on profit margins imposed by India’s drug pricing authority on 42 anti-cancer drugs will have a limited impact on patients’ expenses because many of these medicines’ prices remain “prohibitive”, a network of patients’ rights groups said on Saturday. The All India Drug Action Network (Aidan) said the National Pharmaceutical Pricing Authority’s cap on profit margins in effect “legitimises” the...

-ThePrint.in CPR report says healthcare centres don’t meet standards designed by health ministry in terms of infrastructure, manpower, medical equipment and drugs. New Delhi: Not a single rural healthcare centre in 15 Indian states meets the bare minimum quality standards — set by the Ministry of Health and Family Welfare — such as establishing essential infrastructure, employing the minimum mandated manpower apart from buying required medical equipment and drugs. The findings are part...

-The Hindu Business Line MUMBAI: The government on Monday constituted a standing committee headed by Niti Aayog to oversee the drug pricing regime, a move which could clip the powers of drug pricing regulator, National Pharmaceutical Pricing Authority (NPPA). The Standing Committee on Affordable Medicines and Health Products will be headed by NITI Aayog member (health), and includes chief economic adviser, besides secretary department of health research, director general of health...